Entheogens
Please use the following links to access the following substances:
Ayahuasca - A hallucinogenic tea originally from the Amazon Basin.
LSD - potent mood-changing and perception-altering drug.
Peyote - small cactus with mescaline as the principal active ingredient and effects similar to LSD.
Psilocybin - hallucinogenic mushrooms indigenous to tropical regions like Mexico.
Salvia Divinorum - a perennial herb native to certain areas of Mexico with effects similar to LSD.
__________________________________________________________
(entheogens - definition) "The word entheogen is believed to translate into the phrase “God inside us”10. In the literal sense this word refers to plants, shrubs, fungi and seeds used for centuries in religious or shamanic rituals for the purpose of obtaining revelations, spiritual enlightenment, or healing illnesses. Some of these substances include, Ayahuasca, Amanitas Muscaria, Blue Lotus, Hawaiian Baby Woodrose and Morning Glory Seeds, Salvia Divinorum, Khat, Kanna, San Pedro Cacti, Kratom, Henbane, Yopo and Mandrake. There are many more, some of which are illegal (such as DMT, Kava Kava, Cannabis and Psilocybin Mushrooms) but many are legal still in the UK."
Source:Goold, Patrick R., "The Use of Entheogen Drugs in the United Kingdom: A Misuse of Drugs or a Lawful Expression of the Right to Religion?" (2009). Cornell Law School Graduate Student Papers. Paper 20, p. 5.
http://scholarship.law.cornell.edu/cgi/viewcontent.cgi?article=1000&cont...(entheogens - definition) "In our Western culture psychoactive substances are usually regarded as ‘drugs’. However, in many other societies, all over the world and throughout human history, such substances have been used as sacraments, that is, principal instruments of religious rituals and spiritual work. Indeed, nowadays, an increasing number of people refer to the psychoactive agents more generally known as psychedelics (etymologically, mind manifesting) or hallucinogenic by the term entheogens — that is, agents that bring one in touch with the Divine within (Ruck et al., 1979; Ott, 1996)."
Source:Shanon, Benny, "Entheogens: Reflections on ‘Psychoactive Sacramentals,’" Journal of Consciousness Studies (Exeter, United Kingdom: April 2002) Volume 9, No. 4, p. 85.
http://www.imprint.co.uk/pdf/Roberts.pdf(entheogens - history) "...the first scholar to highlight the sacramental use of psychoactive substances was de Felice (1936/1975 in his book Poisons sacrés, ivresses divines (which so far as I know has not to have been translated into English; this would explain why it is not cited in this collection). De Felice puts forward the hypothesis that the use of psychotropic substances is deeply embedded in human culture, and that it is intrinsically intertwined in a most basic human instinct — the search for transcendence."
Source:Shanon, Benny, "Entheogens: Reflections on ‘Psychoactive Sacramentals,’" Journal of Consciousness Studies (Exeter, United Kingdom: April 2002) Volume 9, No. 4, p. 86.
http://www.imprint.co.uk/pdf/Roberts.pdf(entheogens - hallucingen - definition) "The term “hallucinogen” is widely used and understood in both professional and lay circles, in spite of the fact that hallucinations in the strict psychiatric sense of the word are a relatively rare effect of these drugs (Hollister 1962). What is probably the first reference to hallucinations as produced by peyote appears in Louis Lewin’s book published in 1924 in German and later translated into English with the nearly identical title Phantastica (Lewin 1924, 1964). In this book by the noted German toxicologist, the term “hallucinatoria” appears as a synonym for phantastica to designate the class of drugs that can produce transitory visionary states “without any physical inconvenience for a certain time in persons of perfectly normal mentality who are partly or fully conscious of the action of the drug” (Lewin 1964, p. 92). Lewin lists peyotl (also spelled “peyote”) (Anhalonium lewinii), Indian hemp (Cannabis indica), fly agaric (Agaricus muscarius), thornapple (Datura stramonium), and the South American yahe (also spelled “yage”) (Banisteria caapi) as representatives of this class."
Source:Szára, Stephen, "Are Hallucinogens Psychoheuristic," National Institute on Drug Abuse Research Monograph Series (Rockville, MD: U.S. Department of Health and Human Services, Public Health Service, National Institutes of Health, 1994) NIDA Research Monograph 146, p. 34.
http://archives.drugabuse.gov/pdf/monographs/146.pdf(entheogens - effects) "Another peculiar effect of these drugs is a dramatic change in perception: it appears to the person as if the eyes (the “doors of perception”) have been cleansed and the person could see the world as new in all respects — “as Adam may have seen it on the day of creation” as Aldous Huxley (1954, p. 17) pointed out in his popular and influential book. This new reality is perceived and interpreted by some individuals as manifestation of the true nature of their mind; hence, the term “psychedelic” was suggested by Osmond (1957). This interpretation has been embraced not only by professional therapists but also by some segments of the public, and gave rise to the “Summer of Love” in San Francisco in 1967 with free distribution of LSD. This perception resulted in the formation of numerous cults, communes, and drug-oriented religious groups (Freedman 1968), permeated the lyrics and style of popular music (acid rock), and was viewed by some as one of the contributing sources of the occasional resurgence of popularity of illegal drug use (Cohen 1966, Szára 1968)."
Source:Szára, Stephen, "Are Hallucinogens Psychoheuristic," National Institute on Drug Abuse Research Monograph Series (Rockville, MD: U.S. Department of Health and Human Services, Public Health Service, National Institutes of Health, 1994) NIDA Research Monograph 146, p. 36.
http://archives.drugabuse.gov/pdf/monographs/146.pdfEntheogens - Ayahuasca
(entheogens - ayahuasca - definition) "Ayahuasca (translated into “Vine of the Souls” from the Quechuan language) is a tea made from the infusions of the Banisteropsis Caapi vine and N,N-dimethyltryptamine containing shrub, Psychotria Viridis. Its use was first documented by Schultes in the 1950s where he found it being employed for divinatory purposes by Shamans in Amazonian Colombia13. However, its use has been documented in Peru, Brazil and Ecuador as well14 ... The resulting tea contains the strong hallucinogenic alkaloid, N,Ndimethyltryptamine (DMT), and MAO inhibiting harmala alkaloids, which are necessary to make the DMT orally active."
Source:Goold, Patrick R., "The Use of Entheogen Drugs in the United Kingdom: A Misuse of Drugs or a Lawful Expression of the Right to Religion?" (2009). Cornell Law School Graduate Student Papers. Paper 20, p. 7.
http://scholarship.law.cornell.edu/cgi/viewcontent.cgi?article=1000&cont...(entheogens - ayahuasca - definition & legal status) "Ayahuasca is a hallucinogenic tea originally from the Amazon Basin that is supposedly able to induce strikingly similar visions in people independent of their cultural background. Ayahuasca users commonly claim that this regularity across people’s visions is evidence that their visions are not simply the products of their own brains, but rather are representations of spiritual information learned from plant-spirits that one gains access to by drinking the tea."
"On February 21 of this year, 2006, the US Supreme Court ruled in favor of the Centro Espírita Beneficente União do Vegetal (the UDV) in the case “Alberto R. Gonzales, Attorney General, et al. Petitioners v. O Centro Espirita Beneficente União do Vegetal et al.” The UDV is now legally allowed to drink ayahuasca (which contains the controlled substance DMT) in their ceremonies here in the US."
Source:Anderson, Brian, ""Entheogenic Visions: The Sacred Union of Word & Image," Undergraduate Humanities Forum, Mellon Research Fellows 2005-2006, Word & Image (Philadelphia, PA: May 5, 2006), pp. 2 and 30.
http://repository.upenn.edu/cgi/viewcontent.cgi?article=1000&context=uhf...(etheogens - ayahuasca - definition) "Ayahuasca is a psychedelic decoction made from plants native to the Amazon Basin—most often Banisteriopsis caapi and Psychotria viridis—and which contains harmala alkaloids and N,Ndimethyltryptamine (DMT), the latter being a controlled substance scheduled under the 1971 Convention on Psychotropic Substances.
Source:Anderson, B. T.; Labate, B. C.; Meyer, M.; Tupper, K. W.; Barbosa, P. C. R.; Grob, C. S.; Dawson, A. & McKenna, D., "Statement on ayahuasca,". International Journal of Drug Policy (London, United Kingdom: International Harm Reduction Association, March 2012) Vol. 23, No. 2.
http://www.ncbi.nlm.nih.gov/pubmed/22459485(entheogens - ayahuasca - healing ceremonies) "Vegetalismo is a Peruvian Spanish term denoting the folk healing traditions of mestizo curanderos, or healers of mixed indigenous and non-indigenous ancestry who use ayahuasca and other ―master‖ plants for diagnosis and treatment of illnesses (Beyer, 2009; Dobkin de Rios, 1972; Luna, 1986). Known as ayahuasqueros, such folk healers undergo a rigorous process of initiation and training, requiring adherence to strict dietary and sexual abstinence protocols, and sometimes prolonged isolation in the jungle."
"Cross-cultural vegetalismo refers to ayahuasca ceremonies based, to varying degrees, on vegetalismo or equivalent traditions from other regions of the Amazon, but conducted primarily for (and increasingly by) non-Amazonians. Urban centres in the region are presently witnessing a boom in what has been pejoratively characterized as "ayahuasca tourism" (Dobkin de Rios, 1994; see also Davidov, 2010; Holman, 2011; Razam, 2009), but cross-cultural vegetalismo ceremonies are also increasingly common outside the Amazon (Labate, 2004). Canadians and other foreigners regularly invite indigenous or mestizo Amazonian ayahuasqueros to their home countries to conduct ceremonies for people in the circles and networks of the sponsor‘s friends and acquaintances (Tupper, 2009a—see Appendix). Some individuals are undertaking apprenticeships in the vegetalismo tradition to become neo-shamanic practitioners of ayahuasca healing, in a manner similar to how yoga, Buddhist monastic, ayurvedic, or Chinese medicine practices have been taken up by modern Western disciples exogenous to the respective cultures and traditions of origin."
Source:Tupper, Kenneth William, "Ayahuasca, Entheogenic Education & Public Policy," University of British Columbia (Vancouver, BC: April 2011), pp. 14-15.
http://www.kentupper.com/resources/Ayahuasca+Entheogenic+Educ+$26+Public+Policy+-+Tupper+2011.pdf(enthoegens - ayahuasca - therapeutic potential) "Aside from indicating a general lack of harm from the religious use of ayahuasca, biomedical and ethnographic studies have also generated preliminary evidence in support of the therapeutic potentials of ayahuasca or its constituents for alleviating substance dependence (Grob et al., 1996; Labate, Santos, Anderson, Mercante, & Barbosa, 2010) and mood and anxiety disorders (Fortunato et al., 2010; Santos, Landeira-Fernandez, Strassman, Motta, & Cruz, 2007). The study of ayahuasca could thus contribute to advances in ethnopharmacology and the cognitive sciences (Shanon, 2002), yet such studies are severely compromised when these traditions face the threat of legal sanction."
Source:Anderson, B. T.; Labate, B. C.; Meyer, M.; Tupper, K. W.; Barbosa, P. C. R.; Grob, C. S.; Dawson, A. & McKenna, D., "Statement on ayahuasca,". International Journal of Drug Policy (London, United Kingdom: International Harm Reduction Association, March 2012) Vol. 23, No. 2.
http://www.ncbi.nlm.nih.gov/pubmed/22459485Entheogens - LSD
(entheogens - LSD - overview) "LSD (d-lysergic acid diethylamide) is one of the most potent mood-changing chemicals. It was discovered in 1938 and is manufactured from lysergic acid, which is found in ergot, a fungus that grows on rye and other grains."
Brain effect: "Sensations and feelings change much more dramatically than the physical signs in people under the influence of LSD. The user may feel several different emotions at once or swing rapidly from one emotion to another. If taken in large enough doses, the drug produces delusions and visual hallucinations. The user’s sense of time and self is altered. Experiences may seem to “cross over” different senses, giving the user the feeling of hearing colors and seeing sounds. These changes can be frightening and can cause panic."
"LSD users can also experience flashbacks, or recurrences of certain aspects of the drug experience. Flashbacks occur suddenly, often without warning, and may do so within a few days or more than a year after LSD use."
"Most users of LSD voluntarily decrease or stop its use over time. LSD is not considered an addictive drug since it does not produce compulsive drug-seeking behavior. However, LSD does produce tolerance, so some users who take the drug repeatedly must take progressively higher doses to achieve the state of intoxication that they had previously achieved."
Adverse effects "The effects of LSD depend largely on the amount taken. LSD causes dilated pupils; can raise body temperature and increase heart rate and blood pressure; and can cause profuse sweating, loss of appetite, sleeplessness, dry mouth, and tremors."
Source:NIDA InfoFacts, "Hallucinogens: LSD, Peyote, Psilocybin, and PCP" National Institute on Drug Abuse (Bethesda, MD: National Institutes of Health, June 2009).
http://www.drugabuse.gov/sites/default/files/hallucinogens09.pdf(entheogens - LSD - physical characteristics) "LSD is a clear or white, odorless, water-soluble material synthesized from lysergic acid, a compound derived from a rye fungus. LSD is the most potent mood- and perception-altering drug known: oral doses as small as 30 micrograms can produce effects that last 6 to 12 hours. LSD is initially produced in crystalline form. The pure crystal can be crushed to powder and mixed with binding agents to produce tablets known as “microdots” or thin squares of gelatin called “window panes”; more commonly, it is dissolved, diluted, and applied to paper or other materials. The most common form of LSD is called “blotter acid”—sheets of paper soaked in LSD and perforated into 1/4-inch square, individual dosage units. Variations in manufacturing and the presence of contaminants can produce LSD in colors ranging from clear or white, in its purest form, to tan or even black."
Source:"Hallucinogens and Dissociative Drugs, including LSD, PCP, Ketamine, Dextromethorphan," National Institute on Drug Abuse Research Report Series (Rockville, MD: U.S. Department of Health and Human Services, Public Health Service, National Institutes of Health, 2001), p. 3.
http://www.eric.ed.gov/PDFS/ED453460.pdf(entheogens - LSD - history) "Chemist Albert Hofmann, working at the Sandoz Corporation pharmaceutical laboratory in Switzerland, first synthesized LSD in 1938. He was conducting research on possible medical applications of various lysergic acid compounds derived from ergot, a fungus that develops on rye grass. Searching for compounds with therapeutic value, Hofmann created more than two dozen ergot-derived synthetic molecules. The 25th was called, in German, Lyserg-Säure-Diäthylamid 25, or LSD-25."
Source:"Hallucinogens and Dissociative Drugs, including LSD, PCP, Ketamine, Dextromethorphan," National Institute on Drug Abuse Research Report Series (Rockville, MD: U.S. Department of Health and Human Services, Public Health Service,
National Institutes of Health, 2001), p. 3.
http://www.eric.ed.gov/PDFS/ED453460.pdf(entheogens - LSD - effects) "The physiological effects of this powerful drug have been well documented. These effects can be grouped into five general areas of action: LSD works on the sympathetic nervous system (which is involved in regulation of heart muscle, smooth muscle and glandular organs in a response to stressful situations); the motor system (which is involved in carrying out limb movements); the affective states; thought processes; and it has profound effects upon the sensory and perceptual experience.
"LSD is a semisynthetic preparation originally derived from ergot, an extract of the fungus Claviceps purpurea, which grows as a parasite on rye wheat. The dosage that is required to produce a moderate effect in most subjects is 1 to 3mcg per kilogram of body mass, and the effects can last from seven to 10 hours (Bowman & Rand 1980).
"Stimulation of the sympathetic nervous system following LSD ingestion can lead to effects such as hypothermia with piloerection (hairs standing on end, such as can be found in reports of religious ecstasy), sweating, increased heart rate with palpitations, and elevation of blood pressure and blood glucose levels. These reactions of the autonomic nervous system are not as significant as other effects upon the body: action on the motor system can lead to increased activity of monosynaptic reflexes (such as the knee-jerk response), an increase in muscle tension, tremors, and muscular incoordination. This latter effect of muscular incoordination is also a symptom of religious ecstasy in many cultures, where the worshipper has such a profound feeling of love of God that he is said to be “intoxicated by God.”"
Source:Goodman, Neil, "The Serotonergic System and Mysticism: Could LSD and the Nondrug-Induced Mystical Experience Share Common Neural Mechanisms?" Journal of Psychoactive Drugs (San Francisco, CA: Haight Ashbury Publications, July-September 2002), Vol. 34, No. 3, p. 266.
http://www.cnsproductions.com/pdf/Goodman.pdf(2003 - LSD and marijuana use by women and race) "Our results indicate that this population of sexually active female adolescents and young adults have similar rates of lifetime use of LSD (13%) as reported in other surveys,1,30 and half of these young women report using LSD one or more times in the last year. Prior data suggests that the use of hallucinogens by African Americans is virtually nonexistent across all ages of adolescents and young adults.2,9 In fact, we found that none of our African American young women reported using LSD. However, the proportion of African Americans who reported using marijuana was much greater than either caucasian or Mexican American women."
Source:Rickert, Vaughn I.; Siqueira, Lorena M.; Dale, Travis; and Wiemann, Constance M., "Prevalence and Risk Factors for LSD Use among Young Women," Journal of Pediatric and Adolescent Gynecology (Washington, DC: North American Society for Pediatric and Adolescent Gynecology, April 2003) Volume 16, Issue 2, p. 72.
http://www.beckleyfoundation.org/bib/doc/bf/2003_Rickert_11457_1.pdfEntheogens - Peyote
(entheogens - peyote - overview) "Peyote is a small, spineless cactus in which the principal active ingredient is mescaline. This plant has been used by natives in northern Mexico and the southwestern United States as a part of religious ceremonies. Mescaline can also be produced through chemical synthesis."
"The top of the peyote cactus, also referred to as the crown, consists of disc-shaped buttons that are cut from the roots and dried. These buttons are generally chewed or soaked in water to produce an intoxicating liquid. The hallucinogenic dose of mescaline is about 0.3 to 0.5 grams, and its effects last about 12 hours. Because the extract is so bitter, some individuals prefer to prepare a tea by boiling the cacti for several hours."
Brain effects: "The long-term residual psychological and cognitive effects of mescaline, peyote’s principal active ingredient, remain poorly understood. A recent study found no evidence of psychological or cognitive deficits among Native Americans that use peyote regularly in a religious setting.2 It should be mentioned, however, that these findings may not generalize to those who repeatedly abuse the drug for recreational purposes. Peyote abusers may also experience flashbacks."
Adverse effects "Its effects can be similar to those of LSD, including increased body temperature and heart rate, uncoordinated movements (ataxia), profound sweating, and flushing. The active ingredient mescaline has also been associated, in at least one report, to fetal abnormalities."
Source:NIDA InfoFacts, "Hallucinogens: LSD, Peyote, Psilocybin, and PCP" National Institute on Drug Abuse (Bethesda, MD: National Institutes of Health, June 2009)
http://www.drugabuse.gov/pdf/infofacts/Hallucinogens09.pdfEntheogens - Psilocybin
(entheogens - psilocybin - overview) "Psilocybin (4-phosphoryloxy-N,N-dimethyltryptamine) is obtained from certain types of mushrooms that are indigenous to tropical and subtropical regions of South America, Mexico, and the United States. These mushrooms typically contain less than 0.5 percent psilocybin plus trace amounts of psilocin, another hallucinogenic substance."
"Mushrooms containing psilocybin are available fresh or dried and are typically taken orally. Psilocybin (4-phosphoryloxy-N,N-dimethyltryptamine) and its biologically active form, psilocin (4-hydroxy-N,N-dimethyltryptamine), cannot be inactivated by cooking or freezing preparations. Thus, they may also be brewed as a tea or added to other foods to mask their bitter flavor. The effects of psilocybin, which appear within 20 minutes of ingestion, last approximately 6 hours."
Brain Effect "The active compounds in psilocybin-containing “magic” mushrooms have LSD-like properties and produce alterations of autonomic function, motor reflexes, behavior, and perception.3 The psychological consequences of psilocybin use include hallucinations, an altered perception of time, and an inability to discern fantasy from reality. Panic reactions and psychosis also may occur, particularly if a user ingests a large dose. Long-term effects such as flashbacks, risk of psychiatric illness, impaired memory, and tolerance have been described in case reports."
Adverse Effects "[Psilocybin] can produce muscle relaxation or weakness, ataxia, excessive pupil dilation, nausea, vomiting, and drowsiness. Individuals who abuse psilocybin mushrooms also risk poisoning if one of many existing varieties of poisonous mushrooms is incorrectly identified as a psilocybin mushroom."
Source:NIDA InfoFacts, "Hallucinogens: LSD, Peyote, Psilocybin, and PCP" National Institute on Drug Abuse (Bethesda, MD: National Institutes of Health, June 2009)
http://www.drugabuse.gov/pdf/infofacts/Hallucinogens09.pdf(entheogens - psilocybin - definition) "Today, the medical value of hallucinogens is again being examined in formal psychiatric settings. One substance under investigation is psilocybin, 4-phosphoryloxy-N,N-dimethyltryptamine, which occurs in nature in various species of mushrooms. Psilocybin is rapidly metabolized to psilocin, which is a potent agonist at serotonin 5-HT1A/2A/2C receptors, with 5-HT2A receptor activation directly correlated with human hallucinogenic activity.16 Psilocybin was studied during the 1960s to establish its psychopharmacological profile; it was found to be active orally at around 10 mg, with stronger effects at higher doses, and to have a 4- to 6-hour duration of experience. Psychological effects were similar to those of lysergic acid diethylamide (LSD), with psilocybin considered to be more strongly visual, less emotionally intense, more euphoric, and with fewer panic reactions and less chance of paranoia than LSD."17,18
Source:Grob, Charles S.; Danforth, Alicia L.; Chopra, Gurpreet S.; Hagerty, Marycie; McKay, Charles R.; Halberstadt, Adam L.; Greer, George R., "Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer, "Archives of General Psychiatry," (Chicago, IL: American Medical Association, January 2011), Volume 68, Number 1, p. 71.
http://www.scribd.com/doc/37039374/Pilot-Study-of-Psilocybin-Treatment-i...(entheogens - psilocybin - effects) "An important finding of the present study is that, with careful volunteer screening and preparation and when sessions are conducted in a comfortable, well-supervised setting, a high dose of 30 mg/70 kg psilocybin can be administered safely ... No volunteer required pharmacological intervention and the psychological effects were readily managed with reassurance ... To date, there have been no reports of persisting perceptional phenomena sometimes attributed to hallucinogen use or of recreational abuse of hallucinogens, and all participants appear to continue to be high-functioning, productive members of society.
"The results of the present study have implications for understanding the abuse of hallucinogens. Although psilocybin is regulated by the federal government under the most restrictive category (Schedule I) of the Controlled Substances Act, the National Institute on Drug Abuse (2001, 2005) does not consider psilocybin and the other classical hallucinogens to be drugs of “addiction” because they do not produce compulsive drug-seeking behavior as do classic addicting drugs such as cocaine, amphetamine, heroin, and alcohol."
Source:Griffiths, R. R.; Richards, W. A.; McCann, U.; Jesse, R., " Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance,"Psychopharmacology (Heidelberg, Germany: August 2006), Volume 187, Number 3, p. 281.
http://www.hopkinsmedicine.org/bin/s/m/GriffithsPsilocybin.pdf(entheogens - psilocybin - mystical experiences) "Overall, the present study shows that psilocybin can dose-dependently occasion mystical-type experiences having persisting positive effects on attitudes, mood, and behavior. The observations that episodes of extreme fear, feeling trapped, or delusions occur at the highest dose in almost 40% of volunteers, that anxiety and fear have an unpredictable time course across the session, and that an ascending sequence of dose exposure may be associated with long-lasting positive changes have implications for the design of therapeutic trials with psilocybin. Considering the rarity of spontaneous mystical experiences in the general population, the finding that more than 70% of volunteers in the current study had “complete” mystical experiences suggests that most people have the capacity for such experiences under appropriate conditions and, therefore, such experiences are biologically normal."
Source:Griffiths, Roland R.; Johnson, Matthew W.; Richards, William A.; Richards, Brian D.; McCann, Una; and Jesse, Robert, Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effects," Psychopharmacology (Heidelberg, Germany: May 2011), p. 16.
http://www.springerlink.com/content/u464377x433p5957/fulltext.pdf(entheogens - psilocybin - effects) "Our investigations provided no cause for concern that administration of PY [psilocybin] to healthy subjects is hazardous with respect to somatic health. However, as our data revealed tendencies of PY to temporarily increase blood pressure, we advise subjects suffering from cardiovascular conditions, especially untreated hypertension, to abstain from using PY or PY-containing mushrooms. Furthermore, our results indicate that PY-induced ASC [altered states of consciousness] are generally well tolerated and integrated by healthy subjects. However, a controlled clinical setting is needful, since also mentally stable personalities may, following ingestion of higher doses of PY, transiently experience anxiety as a consequence of loosening of ego-boundaries."
Source:Hasler, Felix; Grimberg, Ulrike; Benz , Marco A.; Huber, Theo; and Vollenweider, Franz, "Acute psychological and physiological effects of psilocybin in healthy humans: a double-blind, placebo-controlled dose–effect study," Psychopharmacology (Heidelberg, Germany: March 2004) Volume 172, Number 2, p. 151.
http://www.beckleyfoundation.org/bib/doc/ah/2003/2003_hasler_6232_1.pdf(treatment of end-stage cancer anxiety with psilocybin) "... this study demonstrates that the careful and controlled use of psilocybin may provide an alternative model for the treatment of conditions that are often minimally responsive to conventional therapies, including the profound existential anxiety and despair that often accompany advanced-stage cancers. A recent review from the psilocybin research group at Johns Hopkins University describes the critical components necessary for ensuring subject safety in hallucinogen research.36 Taking into account these essential provisions for optimizing safety as well as adhering to strict ethical standards of conduct for treatment facilitators, the results provided herein indicate the safety and promise of continued investigations into the range of medical effects of hallucinogenic compounds such as psilocybin."
Source:Grob, Charles S.; Danforth, Alicia L.; Chopra, Gurpreet S.; Hagerty, Marycie; McKay, Charles R.; Halberstadt, Adam L.; Greer, George R., "Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer, "Archives of General Psychiatry," (Chicago, IL: American Medical Association, January 2011), Volume 68, Number 1, p. 77.
http://www.scribd.com/doc/37039374/Pilot-Study-of-Psilocybin-Treatment-i...Entheogens - Salvia Divinorum or Salvinorin A
(entheogens - salvia divinorum - definition) "Salvia divinorum is a perennial herb in the mint family native to certain areas of the Sierra Mazateca region of Oaxaca, Mexico. The plant, which can grow to over three feet in height, has large green leaves, hollow square stems and white flowers with purple calyces, can also be grown successfully outside of this region. Salvia divinorum has been used by the Mazatec Indians for its ritual divination and healing. The active constituent of Salvia divinorum has been identified as salvinorin A. Currently, neither Salvia divinorum nor any of its constituents, including salvinorin A, are controlled under the federal Controlled Substances Act (CSA)."
Source:Drug Enforcement Administration, Office of Diversion Control, "Salvia Divinorum and Salvinorin A," (Washington, DC: U.S. Department of Justice, November 2008)
http://www.justice.gov/dea/concern/salvia_divinorum_one_pager.pdf(entheogens - salvia divinorum - effects) "Consistent with results from nonhuman animal research (Mowry et al.,2003), the present results suggest a safe physiological profile for salvinorin A at the studied doses, under controlled conditions, and in psychologically and physically healthy hallucinogen-experienced participants. Salvinorin A produced no significant changes in heart rate or blood pressure; no tremor was observed; and no adverse events were reported. Participants tolerated all doses. However, because of the small sample and the healthy, hallucinogen-experienced status of participants, conclusions regarding safety are limited."
Source:Johnson, Matthew W.; MacLean, Katherine A.; Reissig, Chad R.; Prisinzano, Thomas E.; Griffiths, Roland R., "Human sychopharmacology and dose-effects of salvinorin A, a kappa opioid," Drug and Alcohol Dependence (Philadelphia, PA: The College on Problems of Drug Dependence, December 3, 2010), p. 4-5.
http://www.washingtonpost.com/wp-srv/nation/pdfs/salviapaper.pdf(entheogens - salvia divinorum - effects) "Many news reports have analogized the plant’s effects with that of LSD.43
"Those effects are caused by a trans-neoclerodane diterpenoid known as Salvinornin A (chemical forumual C23H28O8)44. After ingestion the onset of the effects are almost immediate. If smoked the onset will be between 20 and 60 seconds.45 The total duration lasts between 20 minutes and 45 minutes46. The effects are variable but include powerful open and closed eye visuals, altered perceptions, change in body temperature, sensation of pressure, a dreamlike state and inability to control muscles and maintain balance.47
Source:Goold, Patrick R., "The Use of Entheogen Drugs in the United Kingdom: A Misuse of Drugs or a Lawful Expression of the Right to Religion?" (2009). Cornell Law School Graduate Student Papers. Paper 20, p. 13.
http://scholarship.law.cornell.edu/cgi/viewcontent.cgi?article=1000&cont...(entheogens - salvia divinorum - effects) "The putative primary psychoactive agent in SD [Salvia divinorum] is a structurally novel KOR [kappa opioid receptor] agonist named salvinorin A (Ortega et al., 1982; Valdés et al., 1984). Consistent with KOR agonist activity, users describe SD in lay literature as hallucinogenic: it produces perceptual distortions, pseudo-hallucinations, and a profoundly altered sense of self and environment, including out-of-body experiences (Aardvark, 1998; Erowid, 2008; Siebert, 1994b; Turner, 1996). SD therefore appears to have the potential to elucidate the role of the KOR receptor system in health and disease (Butelman et al., 2004; Chavkin et al., 2004; Roth et al., 2002)."
Source:Baggott, Matthew J.; Earth Erowid; Fire Erowid; Galloway, Gantt P.; Mendelson, John, "Use patterns and self-reported effects of Salvia divinorum: An internet-based survey," Drug and Alcohol Dependence (Philadelphia, PA: College on Problems of Drug Dependence, October 2010), p. 2.
http://www.maps.org/w3pb/new/2010/2010_Baggott_23125_1.pdf
http://www.ncbi.nlm.nih.gov/pubmed/20627425(entheogens - salvia divinorum - abuse liability) "There was little evidence of dependence in our survey population. At some point, 0.6% (3 people) felt addicted to or dependent upon SD, while 1.2% (6) reported strong cravings for SD. The DSM-IV-R psychiatric diagnostic system in the United States classifies people as drug dependent based on seven criteria. Of the three who reported feelings of addiction or dependence on SD, only one endorsed any DSM-IV criteria (strong cravings and using more SD than planned). When asked about these signs and symptoms individually, 2 additional respondents (0.4%) reported three dependence criteria. None of these individuals reported more than 2 of 13 after-effects characteristic of mu-opioid withdrawal (such as increased sweating, gooseflesh, worsened mood, and diarrhea)."
Source:Baggott, Matthew J.; Earth Erowid; Fire Erowid; Galloway, Gantt P.; Mendelson, John, "Use patterns and self-reported effects of Salvia divinorum: An internet-based survey," Drug and Alcohol Dependence (Philadelphia, PA: College on Problems of Drug Dependence, October 2010), p. 4.
http://www.maps.org/w3pb/new/2010/2010_Baggott_23125_1.pdf


